IL165017A0 - Non-sedating barbiturate compounds as neuroprotective agents - Google Patents
Non-sedating barbiturate compounds as neuroprotective agentsInfo
- Publication number
- IL165017A0 IL165017A0 IL16501704A IL16501704A IL165017A0 IL 165017 A0 IL165017 A0 IL 165017A0 IL 16501704 A IL16501704 A IL 16501704A IL 16501704 A IL16501704 A IL 16501704A IL 165017 A0 IL165017 A0 IL 165017A0
- Authority
- IL
- Israel
- Prior art keywords
- neuroprotective agents
- sedative
- sedating barbiturate
- barbiturate compounds
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22167200P | 2000-07-26 | 2000-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL165017A0 true IL165017A0 (en) | 2005-12-18 |
Family
ID=22828824
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15406001A IL154060A0 (en) | 2000-07-26 | 2001-07-26 | Mon-sedating barbiturate compounds as neuroprotective agents |
IL154060A IL154060A (en) | 2000-07-26 | 2003-01-20 | Non-anesthetic barbiturate compounds as preparations for moisturizers |
IL16501704A IL165017A0 (en) | 2000-07-26 | 2004-11-03 | Non-sedating barbiturate compounds as neuroprotective agents |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15406001A IL154060A0 (en) | 2000-07-26 | 2001-07-26 | Mon-sedating barbiturate compounds as neuroprotective agents |
IL154060A IL154060A (en) | 2000-07-26 | 2003-01-20 | Non-anesthetic barbiturate compounds as preparations for moisturizers |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1311270B1 (xx) |
JP (1) | JP5047442B2 (xx) |
CN (2) | CN100522172C (xx) |
AT (1) | ATE383159T1 (xx) |
AU (2) | AU2001280778B2 (xx) |
BR (1) | BR0112775A (xx) |
CA (1) | CA2416535C (xx) |
DE (1) | DE60132337T2 (xx) |
ES (1) | ES2300349T3 (xx) |
HK (1) | HK1100814A1 (xx) |
IL (3) | IL154060A0 (xx) |
MX (1) | MXPA03000824A (xx) |
PT (1) | PT1311270E (xx) |
WO (1) | WO2002007729A1 (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6093820A (en) | 1997-10-02 | 2000-07-25 | Taro Pharmaceutical Industries Ltd. | Method and reagents for N-alkylating ureides |
CN100522172C (zh) * | 2000-07-26 | 2009-08-05 | 塔罗制药工业有限公司 | 非镇静巴比土酸盐化合物在制备神经保护剂中的用途 |
US6939873B2 (en) | 2000-07-26 | 2005-09-06 | Taro Pharmaceuticals Industries Limited | Non-sedating barbituric acid derivatives |
US6756379B2 (en) | 2001-07-26 | 2004-06-29 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbiturate compounds as neuroprotective agents |
US7683071B2 (en) | 2000-07-26 | 2010-03-23 | Taro Pharmaceuticals Industries Ltd. | Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid |
WO2003063872A1 (en) * | 2002-01-30 | 2003-08-07 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbituric acid derivatives |
AU2003282464B2 (en) * | 2002-10-11 | 2010-02-25 | Baxter International, Inc. | Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
TW200822927A (en) | 2002-12-11 | 2008-06-01 | Taro Pharmaceuticals Ireland Ltd | Method of treating movement disorders using barbituric acid derivatives |
EP1625848A1 (en) * | 2004-08-10 | 2006-02-15 | Taro Pharmaceuticals North America, Inc. | Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid |
EP2755945A1 (en) * | 2011-09-12 | 2014-07-23 | Council of Scientific & Industrial Research | ARYLATED beta-DICARBONYL COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF |
CN102863579B (zh) * | 2012-09-14 | 2014-02-05 | 东南大学 | 一种巴比妥酸螯合树脂及其制备方法和应用 |
EP3329279B1 (en) | 2015-10-05 | 2021-07-07 | The University of North Carolina at Chapel Hill | Decoding methods for multiplexing assays and associated fluidic devices, kits, and solid supports |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL69722A (en) * | 1983-09-14 | 1986-09-30 | Taro Pharma Ind | Oxopyrimidine derivatives and pharmaceutical compositions containing them |
US4833148A (en) * | 1987-04-09 | 1989-05-23 | Washington University | Method of using alkenyl- or alkynyl-substituted thiobarbiturates to reduce neurotoxic injury |
US5474990A (en) * | 1989-10-20 | 1995-12-12 | Olney; John W. | Barbiturates as safening agents in conjunction with NMDA antagonists |
CN100522172C (zh) * | 2000-07-26 | 2009-08-05 | 塔罗制药工业有限公司 | 非镇静巴比土酸盐化合物在制备神经保护剂中的用途 |
-
2001
- 2001-07-26 CN CNB2006100813267A patent/CN100522172C/zh not_active Expired - Fee Related
- 2001-07-26 AT AT01959195T patent/ATE383159T1/de not_active IP Right Cessation
- 2001-07-26 CA CA2416535A patent/CA2416535C/en not_active Expired - Fee Related
- 2001-07-26 JP JP2002513464A patent/JP5047442B2/ja not_active Expired - Fee Related
- 2001-07-26 CN CNB018151426A patent/CN1329032C/zh not_active Expired - Fee Related
- 2001-07-26 DE DE60132337T patent/DE60132337T2/de not_active Expired - Lifetime
- 2001-07-26 BR BR0112775-6A patent/BR0112775A/pt not_active Application Discontinuation
- 2001-07-26 EP EP01959195A patent/EP1311270B1/en not_active Expired - Lifetime
- 2001-07-26 AU AU2001280778A patent/AU2001280778B2/en not_active Ceased
- 2001-07-26 MX MXPA03000824A patent/MXPA03000824A/es active IP Right Grant
- 2001-07-26 IL IL15406001A patent/IL154060A0/xx unknown
- 2001-07-26 PT PT01959195T patent/PT1311270E/pt unknown
- 2001-07-26 ES ES01959195T patent/ES2300349T3/es not_active Expired - Lifetime
- 2001-07-26 WO PCT/US2001/023420 patent/WO2002007729A1/en active IP Right Grant
- 2001-07-26 AU AU8077801A patent/AU8077801A/xx active Pending
-
2003
- 2003-01-20 IL IL154060A patent/IL154060A/en not_active IP Right Cessation
-
2004
- 2004-11-03 IL IL16501704A patent/IL165017A0/xx unknown
-
2007
- 2007-06-05 HK HK07105924.3A patent/HK1100814A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002007729A1 (en) | 2002-01-31 |
CA2416535A1 (en) | 2002-01-31 |
MXPA03000824A (es) | 2004-11-01 |
EP1311270A1 (en) | 2003-05-21 |
IL154060A0 (en) | 2003-07-31 |
CA2416535C (en) | 2010-11-16 |
DE60132337T2 (de) | 2009-02-12 |
EP1311270B1 (en) | 2008-01-09 |
DE60132337D1 (de) | 2008-02-21 |
BR0112775A (pt) | 2003-12-30 |
EP1311270A4 (en) | 2006-04-12 |
AU8077801A (en) | 2002-02-05 |
ATE383159T1 (de) | 2008-01-15 |
CN100522172C (zh) | 2009-08-05 |
CN1329032C (zh) | 2007-08-01 |
IL154060A (en) | 2013-05-30 |
CN1872067A (zh) | 2006-12-06 |
HK1100814A1 (en) | 2007-09-28 |
ES2300349T3 (es) | 2008-06-16 |
AU2001280778B2 (en) | 2004-09-02 |
JP2004517808A (ja) | 2004-06-17 |
WO2002007729A9 (en) | 2002-08-08 |
JP5047442B2 (ja) | 2012-10-10 |
CN1461219A (zh) | 2003-12-10 |
PT1311270E (pt) | 2008-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1100814A1 (en) | Use of non-sedating barbiturate compounds in preparation of neuroprotective agents | |
AU7315301A (en) | Compounds and compositions for delivering active agents | |
HUP0302792A3 (en) | Cyclopropyl-fused pyrrolidine-based onhibitors of dipeptidyl peptidase iv and method for their preparation and pharmaceutical compositions containing the compounds | |
MXPA02007690A (es) | Composiciones de liberacion controlada que contienen agonista y antiagonista de opioide. | |
MXPA01008611A (es) | Compuestos y composiciones para suministrar agentes activos. | |
CZ2001449A3 (cs) | Sloučeniny a prostředky pro dodávání aktivních látek | |
NZ516347A (en) | Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
HK1048801B (zh) | 用於傳遞活性藥物的苯氧基羧酸化合物和組合物 | |
NZ524138A (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
MXPA02011632A (es) | Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1. | |
TW200505901A (en) | Muscarinic agonists | |
PL378238A1 (pl) | Związki biaromatyczne, które aktywują receptory typu PPAR<$Egamma>, oraz ich zastosowanie w kompozycjach kosmetycznych albo farmaceutycznych | |
MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
WO2002015959A3 (en) | Compounds and compositions for delivering active agents | |
MY124727A (en) | Tri-substituted phenyl derivatives and analogues. | |
GB9907571D0 (en) | Compounds | |
AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
GR3020330T3 (en) | Novel bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds. | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
EP1905441A3 (en) | Non-sedating barbiturate compounds as neuroprotective agents | |
EP1099439A3 (en) | Use of apo B secretion/MTP inhibitors | |
HK1085744A1 (en) | Steroid compounds with anti-tumor activity | |
CO5580753A2 (es) | Composicion farmaceutica que comprende un antagonista ltb4 y un inhibidor cox-2 o un inhibidor cox1/2 | |
WO2006036956A3 (en) | Therapeutic regimen for treating cancer using quassinoids and other chemotherapeutic agents | |
UA33946A (uk) | Спосіб лікування алкогольної хвороби печінки |